{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:33:55Z","timestamp":1793205235980,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015699","name":"Fresenius Medical Care North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.tem.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T16:23:24Z","timestamp":1626107004000},"page":"721-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Mark","family":"Lambie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bonomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Accili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arduino","family":"Arduini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Zammit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2021.06.001_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacbts.2018.04.003","article-title":"Potentiation of insulin signaling contributes to heart failure in type 2 diabetes: a hypothesis supported by both mechanistic studies and clinical trials","volume":"3","author":"Packer","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.tem.2021.06.001_bb0010","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.tem.2021.06.001_bb0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1479164119827611","article-title":"Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: time for a conceptual framework shift","volume":"16","author":"Nolan","year":"2019","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.tem.2021.06.001_bb0020","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2021.06.001_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2021.06.001_bb0030","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.1423952112","article-title":"Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids","volume":"112","author":"Vatner","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2021.06.001_bb0035","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/ncomms6190","article-title":"Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors","volume":"5","author":"Haeusler","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2021.06.001_bb0040","first-page":"1029","article-title":"Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice","volume":"119","author":"Han","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2021.06.001_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"Yecies","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2021.06.001_bb0050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2021.06.001_bb0055","doi-asserted-by":"crossref","first-page":"13972","DOI":"10.1074\/jbc.M115.638197","article-title":"Pathogenesis of selective insulin resistance in isolated hepatocytes","volume":"290","author":"Cook","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2021.06.001_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2002.tb04263.x","article-title":"Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance","volume":"967","author":"Zammit","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2021.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121689","article-title":"Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia","volume":"451","author":"Zammit","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2021.06.001_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ki.2014.351","article-title":"Preserved Na\/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome","volume":"87","author":"Nakamura","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2021.06.001_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5527\/wjn.v8.i1.11","article-title":"Insulin receptors in the kidneys in health and disease","volume":"8","author":"Singh","year":"2019","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0080","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-017-4394-0","article-title":"Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor","volume":"60","author":"Lay","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2021.06.001_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MNH.0000000000000376","article-title":"Protein phosphatases and podocyte function","volume":"27","author":"Geraldes","year":"2018","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.tem.2021.06.001_bb0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2337\/db18-0090","article-title":"Proximal tubular cell-specific ablation of carnitine acetyltransferase causes tubular disease and secondary glomerulosclerosis","volume":"68","author":"Kruger","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2021.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.addr.2009.04.024","article-title":"Carnitine, mitochondrial function and therapy","volume":"61","author":"Zammit","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tem.2021.06.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129034","article-title":"Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2021.06.001_bb0105","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/db16-0152","article-title":"Selective insulin resistance and the development of cardiovascular diseases in diabetes: the 2015 Edwin Bierman Award Lecture","volume":"65","author":"King","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2021.06.001_bb0110","doi-asserted-by":"crossref","first-page":"30947","DOI":"10.1074\/jbc.M115.673988","article-title":"Chronic hyperinsulinemia causes selective insulin resistance and down-regulates uncoupling protein 3 (UCP3) through the activation of sterol regulatory element-binding protein (SREBP)-1 transcription factor in the mouse heart","volume":"290","author":"Harmancey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2021.06.001_bb0115","doi-asserted-by":"crossref","first-page":"H1192","DOI":"10.1152\/ajpheart.00592.2012","article-title":"Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning","volume":"304","author":"Ozcan","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tem.2021.06.001_bb0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI40096","article-title":"Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents","volume":"120","author":"Shimizu","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2021.06.001_bb0125","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2021.06.001_bb0130","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/db15-1552","article-title":"Insulin regulates hepatic triglyceride secretion and lipid content via signaling in the brain","volume":"65","author":"Scherer","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2021.06.001_bb0135","doi-asserted-by":"crossref","first-page":"20462","DOI":"10.1074\/jbc.R114.576355","article-title":"Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux","volume":"289","author":"Otero","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2021.06.001_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2021.06.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6125","article-title":"Association of second-line antidiabetic medications with cardiovascular events among insured adults with type 2 diabetes","volume":"1","author":"O\u2019Brien","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2021.06.001_bb0150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/00325481.2016.1191955","article-title":"Obviating much of the need for insulin therapy in type 2 diabetes mellitus: a re-assessment of insulin therapy\u2019s safety profile","volume":"128","author":"Schwartz","year":"2016","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.tem.2021.06.001_bb0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI110067","article-title":"Insulin resistance in uremia","volume":"67","author":"DeFronzo","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2021.06.001_bb0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1203\/00006450-199608000-00019","article-title":"Insulin resistance in uremia: effect of dialysis modality","volume":"40","author":"Mak","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tem.2021.06.001_bb0165","first-page":"119","article-title":"Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients","volume":"11","author":"Ersoy","year":"1995","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.tem.2021.06.001_bb0170","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.ajkd.2013.04.007","article-title":"Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial","volume":"62","author":"Bonomini","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2021.06.001_bb0175","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ndt\/gfx018","article-title":"Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis","volume":"32","author":"Guthoff","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1159\/000500979","article-title":"Triglyceride glucose index predicting cardiovascular mortality in Chinese initiating peritoneal dialysis: a cohort study","volume":"44","author":"Yan","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.tem.2021.06.001_bb0185","article-title":"Metabolic syndrome increases mortality risk in dialysis patients: a systematic review and meta-analysis","volume":"16","author":"Sanguankeo","year":"2018","journal-title":"Int. J. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.06.001_bb0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3747\/pdi.2014.00223","article-title":"Nonalcoholic fatty liver disease (NAFLD) \u2013 a new cardiovascular risk factor in peritoneal dialysis patients","volume":"36","author":"Mikolasevic","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.tem.2021.06.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107707","article-title":"Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality","volume":"34","author":"Copur","year":"2020","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.tem.2021.06.001_bb0200","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2337\/dc17-0245","article-title":"The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: a report from EUROASPIRE IV: a survey from the European Society of Cardiology","volume":"40","author":"Shahim","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2021.06.001_bb0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc08-0854","article-title":"Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis","volume":"32","author":"Eddy","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2021.06.001_bb0210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/dom.13110","article-title":"Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes","volume":"20","author":"Nystr\u00f6m","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2021.06.001_bb0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","article-title":"Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients","volume":"3","author":"Woodward","year":"2003","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155564","article-title":"Peritoneal dialysate glucose load and systemic glucose metabolism in non-diabetics: results from the GLOBAL fluid cohort study","volume":"11","author":"Lambie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2021.06.001_bb0225","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.ajkd.2007.01.018","article-title":"New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis","volume":"49","author":"Szeto","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2021.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2215\/CJN.06790810","article-title":"Longitudinal body composition changes due to dialysis","volume":"6","author":"Pellicano","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.krcp.2015.12.007","article-title":"Metabolic syndrome and obesity in peritoneal dialysis","volume":"35","author":"Lo","year":"2016","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.tem.2021.06.001_bb0240","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ndt\/gfx250","article-title":"Risk of new-onset diabetes in end-stage renal disease patients undergoing dialysis: analysis from registry data of Taiwan","volume":"33","author":"Wang","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120922628","article-title":"Determinants of poor glycemic control in patients with kidney transplants: a single-center retrospective cohort study in Canada","volume":"7","author":"Chan Chun Kong","year":"2020","journal-title":"Can. J. Kidney Health Dis."},{"key":"10.1016\/j.tem.2021.06.001_bb0250","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/ndt\/gfz116","article-title":"New-onset glucose disorders in peritoneal dialysis patients: a meta-analysis and systematic review","volume":"35","author":"Xue","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0255","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0260","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semnephrol.2011.01.006","article-title":"Determinants of peritoneal membrane function over time","volume":"31","author":"Davies","year":"2011","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semnephrol.2016.10.009","article-title":"Peritoneal membrane preservation","volume":"37","author":"Bajo","year":"2017","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0270","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.tem.2021.06.001_bb0275","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/j.ajkd.2019.10.004","article-title":"Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: an enriched systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Goossen","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2021.06.001_bb0280","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.02380218","article-title":"Biocompatible solutions and long-term changes in peritoneal solute transport","volume":"13","author":"Elphick","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0285","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/sdi.12579","article-title":"\u201cBiocompatible\u201d neutral pH low-GDP peritoneal dialysis solutions: much ado about nothing?","volume":"30","author":"Misra","year":"2017","journal-title":"Semin. Dial."},{"key":"10.1016\/j.tem.2021.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2012100987","article-title":"Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients","volume":"24","author":"Li","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0295","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2012.05.018","article-title":"A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial","volume":"60","author":"Lui","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2021.06.001_bb0300","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/gfv247","article-title":"Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH)","volume":"30","author":"de Moraes","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0305","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2215\/CJN.03170315","article-title":"Insulin resistance in nondiabetic peritoneal dialysis patients: associations with body composition, peritoneal transport, and peritoneal glucose absorption","volume":"10","author":"Bernardo","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0310","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000153248","article-title":"Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease","volume":"26","author":"Jiang","year":"2008","journal-title":"Blood Purif."},{"key":"10.1016\/j.tem.2021.06.001_bb0315","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/ndt\/gfp473","article-title":"Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients","volume":"25","author":"Cho","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0320","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0325","article-title":"Dialysate glucose response phenotypes during peritoneal equilibration test and their association with cardiovascular death: a cohort study","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tem.2021.06.001_bb0330","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMe1512602","article-title":"Cardiovascular risk and sodium\u2013glucose cotransporter 2 inhibition in type 2 diabetes","volume":"373","author":"Ingelfinger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2021.06.001_bb0335","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/CIRCULATIONAHA.119.040130","article-title":"Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus","volume":"139","author":"Kato","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2021.06.001_bb0340","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/dbi19-0026","article-title":"The peripheral peril: injected insulin induces insulin insensitivity in type 1 diabetes","volume":"69","author":"Gregory","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2021.06.001_bb0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/JOE-11-0105","article-title":"Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver","volume":"211","author":"Okamoto","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2021.06.001_bb0350","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","article-title":"Pathophysiology of diabetic dyslipidaemia: where are we?","volume":"58","author":"Verg\u00e8s","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2021.06.001_bb0355","first-page":"1911","article-title":"Beneficial effect of diazoxide in obese hyperinsulinemic adults","volume":"83","author":"Alemzadeh","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2021.06.001_bb0360","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/01.ASN.0000019900.87535.43","article-title":"Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease","volume":"13","author":"Shinohara","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0365","first-page":"85","article-title":"Repeated analysis of estimated insulin resistance using the HOMAIR index in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality","volume":"33","author":"S\u00e1nchez-Villanueva","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.tem.2021.06.001_bb0370","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3747\/pdi.2011.00066","article-title":"Leptin\/adiponectin ratio is an independent predictor of mortality in nondiabetic peritoneal dialysis patients","volume":"33","author":"Park","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.tem.2021.06.001_bb0375","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/dc11-1657","article-title":"Insulin resistance, cystatin C, and mortality among older adults","volume":"35","author":"de Boer","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2021.06.001_bb0380","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/ndt\/16.12.2386","article-title":"Body mass index and mortality in \u201chealthier\u201d as compared with \u201csicker\u201d haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"16","author":"Leavey","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0385","first-page":"439","article-title":"Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis","volume":"32","author":"Ladhani","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0390","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.P084277","article-title":"Lipid levels are inversely associated with infectious and all-cause mortality: International MONDO study results","volume":"59","author":"Kaysen","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2021.06.001_bb0395","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/ndt\/gfl272","article-title":"The association of lipid levels with mortality in patients on chronic peritoneal dialysis","volume":"21","author":"Habib","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0400","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacl.2017.06.004","article-title":"Association of serum lipid levels over time with survival in incident peritoneal dialysis patients","volume":"11","author":"Park","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.tem.2021.06.001_bb0405","article-title":"The atherogenic index of plasma and the risk of mortality in incident dialysis patients: results from a nationwide prospective cohort in Korea","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2021.06.001_bb0410","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2215\/CJN.06620613","article-title":"Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications","volume":"9","author":"Szeto","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0415","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1159\/000502145","article-title":"Metabolic syndrome and mortality in continuous ambulatory peritoneal dialysis patients: a 5-year prospective cohort study","volume":"44","author":"Gu","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.tem.2021.06.001_bb0420","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1093\/ndt\/gfr175","article-title":"Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis","volume":"26","author":"Liao","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.krcp.2014.10.002","article-title":"Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis","volume":"33","author":"Yoon","year":"2014","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.tem.2021.06.001_bb0430","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2013.06.020","article-title":"Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis","volume":"63","author":"Hill","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2021.06.001_bb0435","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08921010","article-title":"Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus","volume":"6","author":"Duong","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2021.06.001_bb0440","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3747\/pdi.2013.00083","article-title":"High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients","volume":"35","author":"Wen","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.tem.2021.06.001_bb0445","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","article-title":"Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis","volume":"224","author":"Jiang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tem.2021.06.001_bb0450","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ndt\/gfx371","article-title":"Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study","volume":"34","author":"Mukai","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2021.06.001_bb0455","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276021001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276021001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:41:41Z","timestamp":1760906501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276021001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1043276021001314"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2021.06.001","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}